Advertisement

Digestive Diseases and Sciences

, Volume 33, Issue 12, pp 1520–1524 | Cite as

Zinc clearance correlates with clinical severity of Crohn's disease

A kinetic study
  • Toshiro Nakamura
  • Akimasa Higashi
  • Sadamu Takano
  • Masanobu Akagi
  • Ichiro Matsuda
Original Articles

Abstract

After peroral and intravenous loading of zinc in 10 patients with Crohn's disease, a kinetic analysis of serum zinc was carried out. The patients were divided into two groups depending on the clinical activity indices (group A: five with active form and group B: five with inactive form). The mean level of serum zinc was significantly reduced in group A patients, but not in group B, when compared to findings in control subjects. A significant reduction in AUCpo (area under the concentration vs time curve by peroral administration), accompanied by increased zinc clearance (ClZn) was also found in group A but not in group B. The ClZn significantly correlated with clinical activity indices. Absorption efficiency, the ratio of AUCpo/AUCiv (area under the concentration vs time curve by intravenous administration), was similar in group A, group B, and the control. Therefore, the absorption of zinc in patients with the disease seems to be intact, regardless of whether they have the active or inactive form of Crohn's disease. The hypozincemia seen in patients with Crohn's disease is presumably related to an accelerated turnover rather than to a malabsorption of zinc.

Key words

Crohn's disease zinc deficiency zinc clearance 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Prasad AS: Clinical biochemical and pharamacological role of zinc. Annu Rev. Pharmacol Toxicol 19:393–426, 1979PubMedGoogle Scholar
  2. 2.
    Machlin LJ, Gabriel E: Interactions of vitamin E with vitamin C, vitamin B12, and zinc. Ann NY Acad Sci 355:98–108, 1980PubMedGoogle Scholar
  3. 3.
    Bettger WJ, O'Delli BL: A critical physiological role of zinc in the structure and function of biomembranes. Life Sci 28:1425–1438, 1981PubMedGoogle Scholar
  4. 4.
    Okabe N: Immunological studies on Crohn's disease. IV decreased ADCC activity. J Clin Lab Immunol 19:77–81, 1986PubMedGoogle Scholar
  5. 5.
    Hansen MA, Fernandes G, Good RA: Nutrition and immunity the influence of diet on autoimmunity and the role of zinc in the immune response. Annu Rev Nutr 2:151–177, 1982PubMedGoogle Scholar
  6. 6.
    McClain C, Soutor C, Zieve L: Zinc deficiency: A complication of Crohn's disease. Gastroenterology 78:272–279, 1980PubMedGoogle Scholar
  7. 7.
    Solomons NW, Rosenberg IH, Sandstead HH, Vo-Khactu KP: Zinc deficiency in Crohn's disease. Digestion 16:87–95, 1977PubMedGoogle Scholar
  8. 8.
    Nishi Y, Lifshitz F, Bayne MA, Daum F, Silverberg M, Aiges H: Zinc status and its relation to growth retardation in children with chronic inflammatory bowel disease. Am J Clin Nutr 33:2613–2621, 1980PubMedGoogle Scholar
  9. 9.
    Brazin SA, Johnson WT, Abramson LJ: The acrodermatitis enteropathica-like syndrome. Arch Dermatol 115:597–599, 1979PubMedGoogle Scholar
  10. 10.
    Standstead HH, Howard L: Zinc deficiency in Crohn's disease. Nutr Rev 40:109–112, 1982PubMedGoogle Scholar
  11. 11.
    McClain CJ, Su LC, Gilbert H, Cameron D: Zinc-deficiency-induced retinal dysfunction in Crohn's disease. Dig Dis Sci 28:85–87, 1983PubMedGoogle Scholar
  12. 12.
    Kirschner BS, Klich JR, Kalman S, DeFavaro MV, Rosenberg IH: Reversal of growth retardation in Crohn's disease with therapy emphasizing oral nutritional restitution. Gastroenterology 80:10–15, 1981PubMedGoogle Scholar
  13. 13.
    Fleming CR, Huizenga KA, McCall JT, Gildea J, Dennis R: Zinc nutrition in Crohn's disease. Dig Dis Sci 26:865–870, 1981PubMedGoogle Scholar
  14. 14.
    Van Hees PAM, Van Elteren PH, Van Lier HJJ, Van Tongeren JHM: An index of inflammatory activity in patients with Crohn's disease. Gut 21:279–286, 1980PubMedGoogle Scholar
  15. 15.
    Sullivan JF, Jetton MM, Burch RE: A zinc tolerance test. J Lab Clin Med 93:485–492, 1979PubMedGoogle Scholar
  16. 16.
    Higashi A, Ikeda T, Uehara I, Matsuda I: Effect of low-content zinc and copper formula on infant nutrition. Eur J Pediatr 138:237–240, 1982PubMedGoogle Scholar
  17. 17.
    Niazi S: Textbook of Biopharmaceutics and Clinical Pharmacokinetics. New York, Appleton-Century-Crofts, 1979Google Scholar
  18. 18.
    Committee on Nutrition. Zinc. Pediatrics 62:408–412, 1978Google Scholar
  19. 19.
    Schoelmerich J, Becher MS, Hoppe-Seyler P, Matern S, Haeussinger D, Loehle E, Koettgen E, Gerok W: Zinc and vitamin A deficiency in patients with Crohn's disease is correlated with activity but not with localization or extent of the disease. Hepato-Gastroenterology 32:34–58, 1985PubMedGoogle Scholar
  20. 20.
    Solomons NW, Elson CO, Pekarek RS, Jacob RA, Sandstead HH, Rosenberg IH: Leukocytic endogenous mediator in Crohn's disease. Infect Immun 22:637–639, 1978PubMedGoogle Scholar
  21. 21.
    Sturniolo GC, Molokhia MM, Shields R, Turnberg LA: Zinc absorption in Crohn's disease. Gut 21:387–391, 1980PubMedGoogle Scholar
  22. 22.
    Sandstead HH: Disorders of Mineral Metabolism. New York, Academic Press, 1981, pp 94–157Google Scholar

Copyright information

© Plenum Publishing Corporation 1988

Authors and Affiliations

  • Toshiro Nakamura
    • 1
  • Akimasa Higashi
    • 1
  • Sadamu Takano
    • 1
  • Masanobu Akagi
    • 1
  • Ichiro Matsuda
    • 1
  1. 1.Department of PediatricsKumamoto University Medical SchoolJapan

Personalised recommendations